Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 
DeviceAgili-C
Generic NameImplant, resorbable, for articular osteochondral repair
ApplicantCartiHeal Ltd.
17 Atir Yeda Street
Kfar Saba 44643
PMA NumberP210034
Date Received09/30/2021
Decision Date03/29/2022
Product Code QRU 
Docket Number 22M-0481
Notice Date 03/30/2022
Advisory Committee Orthopedic
Clinical TrialsNCT03299959
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
Approval for Agili-C. The Agili-C scaffold is indicated for the treatment of an International Cartilage Repair Society (ICRS) grade III or above knee-joint surface lesion(s), with a total treatable area of 1-7cm2, without severe osteoarthritis (Kellgren-Lawrence grade 0-3).
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements:  
-
-